Literature DB >> 12643602

Laminin-5 gamma2 chain expression as a possible determinant of tumor aggressiveness in T1 colorectal carcinomas.

Tadahiko Masaki1, Hiroyoshi Matsuoka, Masanori Sugiyama, Nobutsugu Abe, Yumi Izumisato, Atsuhiko Sakamoto, Yutaka Atomi.   

Abstract

This study was undertaken to clarify the associations between laminin-5 y2 chain expression, and tumor budding and lymph node metastasis or local recurrence (locoregional failure) of 50 T1 colorectal carcinomas immunohistochemically. Fifteen (30%) of 50 lesions were positive for laminin-5 gamma2 chain expression. By univariate analysis, less histological differentiation (P = 0.02), nonpolypoid growth pattern (P = 0.03) and tumorbudding (P < 0.001) were associated with laminin-5 gamma2 chain positivity. By multivariate analysis, tumor budding alone was significantly associated with laminin-5 gamma2 chain positivity (P = 0.006), and correlation between nonpolypoid growth pattern and laminin-5 gamma2 chain positivity lost its significance (P = 0.09). Tumor budding (P = 0.004) and laminin-5 gamma2 chain expression (P = 0.001) were significantly associated with locoregional failure. Laminin-5 gamma2 chain expression may contribute to the formation of budding tumor cells at the invasive front, and immunostaining of this adhesion molecule may be useful in identifying high-risk patients for locoregional failure in T1 colorectal carcinomas.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12643602     DOI: 10.1023/a:1021967108134

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  18 in total

1.  Expression of the invasion factor laminin gamma2 in colorectal carcinomas is regulated by beta-catenin.

Authors:  F Hlubek; A Jung; N Kotzor; T Kirchner; T Brabletz
Journal:  Cancer Res       Date:  2001-11-15       Impact factor: 12.701

2.  Expression of the gamma(2) chain of laminin-5 at the invasive front is associated with recurrence and poor prognosis in human esophageal squamous cell carcinoma.

Authors:  H Yamamoto; F Itoh; S Iku; M Hosokawa; K Imai
Journal:  Clin Cancer Res       Date:  2001-04       Impact factor: 12.531

3.  Possible contribution of CD44 variant 6 and nuclear beta-catenin expression to the formation of budding tumor cells in patients with T1 colorectal carcinoma.

Authors:  T Masaki; A Goto; M Sugiyama; H Matsuoka; N Abe; A Sakamoto; Y Atomi
Journal:  Cancer       Date:  2001-11-15       Impact factor: 6.860

4.  Increased expression of laminin-5 and its prognostic significance in lung adenocarcinomas of small size. An immunohistochemical analysis of 102 cases.

Authors:  Y Moriya; T Niki; T Yamada; Y Matsuno; H Kondo; S Hirohashi
Journal:  Cancer       Date:  2001-03-15       Impact factor: 6.860

5.  Tumor cell budding and laminin-5 expression in colorectal carcinoma can be modulated by the tissue micro-environment.

Authors:  I Sordat; P Rousselle; P Chaubert; O Petermann; D Aberdam; F T Bosman; B Sordat
Journal:  Int J Cancer       Date:  2000-12-01       Impact factor: 7.396

6.  Cancer cell morphology at the invasive front and expression of cell adhesion-related carbohydrate in the primary lesion of patients with colorectal carcinoma with liver metastasis.

Authors:  M Ono; M Sakamoto; Y Ino; Y Moriya; K Sugihara; T Muto; S Hirohashi
Journal:  Cancer       Date:  1996-09-15       Impact factor: 6.860

7.  Non-involvement of ras mutations in flat colorectal adenomas and carcinomas.

Authors:  T Fujimori; K Satonaka; Y Yamamura-Idei; K Nagasako; S Maeda
Journal:  Int J Cancer       Date:  1994-04-01       Impact factor: 7.396

8.  Early colorectal carcinoma with special reference to its development de novo.

Authors:  T Shimoda; M Ikegami; J Fujisaki; T Matsui; S Aizawa; E Ishikawa
Journal:  Cancer       Date:  1989-09-01       Impact factor: 6.860

9.  Policy of local excision for early cancer of the colorectum.

Authors:  B C Morson; H J Bussey; S Samoorian
Journal:  Gut       Date:  1977-12       Impact factor: 23.059

10.  Laminin-5 is a marker of invading cancer cells in some human carcinomas and is coexpressed with the receptor for urokinase plasminogen activator in budding cancer cells in colon adenocarcinomas.

Authors:  C Pyke; S Salo; E Ralfkiaer; J Rømer; K Danø; K Tryggvason
Journal:  Cancer Res       Date:  1995-09-15       Impact factor: 12.701

View more
  10 in total

1.  C4.4A is associated with tumor budding and epithelial-mesenchymal transition of colorectal cancer.

Authors:  Ryota Oshiro; Hirofumi Yamamoto; Hidekazu Takahashi; Masahisa Ohtsuka; Xin Wu; Junichi Nishimura; Ichiro Takemasa; Tsunekazu Mizushima; Masataka Ikeda; Mitsugu Sekimoto; Nariaki Matsuura; Yuichiro Doki; Masaki Mori
Journal:  Cancer Sci       Date:  2012-04-11       Impact factor: 6.716

2.  ABCG5-positivity in tumor buds is an indicator of poor prognosis in node-negative colorectal cancer patients.

Authors:  Lsabel Hostettler; Inti Zlobec; Luigi Terracciano; Alessandro Lugli
Journal:  World J Gastroenterol       Date:  2010-02-14       Impact factor: 5.742

Review 3.  Laminin-5 in epithelial tumour invasion.

Authors:  Masahiko Katayama; Kiyotoshi Sekiguchi
Journal:  J Mol Histol       Date:  2004-03       Impact factor: 2.611

4.  Intensity of tumor budding as an index for the malignant potential in invasive rectal carcinoma.

Authors:  Sang-Sik Ha; Hong-Jo Choi; Ki-Jae Park; Jung-Min Kim; Sung-Heun Kim; Young-Hoon Roh; Hyuk-Chan Kwon; Mee-Sook Roh
Journal:  Cancer Res Treat       Date:  2005-06-30       Impact factor: 4.679

Review 5.  Recent progress in predictive biomarkers for metastatic recurrence of human hepatocellular carcinoma: a review of the literature.

Authors:  Lun-Xiu Qin; Zhao-You Tang
Journal:  J Cancer Res Clin Oncol       Date:  2004-06-17       Impact factor: 4.553

6.  Coexpression of matrilysin and laminin-5 gamma2 chain may contribute to tumor cell migration in colorectal carcinomas.

Authors:  Tadahiko Masaki; Masanori Sugiyama; Hiroyoshi Matsuoka; Nobutsugu Abe; Yumi Izumisato; Atsuhiko Sakamoto; Yutaka Atomi
Journal:  Dig Dis Sci       Date:  2003-07       Impact factor: 3.199

Review 7.  Defining the role of laminin-332 in carcinoma.

Authors:  Cherise M Guess; Vito Quaranta
Journal:  Matrix Biol       Date:  2009-08-15       Impact factor: 11.583

Review 8.  Epithelial mesenchymal transition and tumor budding in aggressive colorectal cancer: tumor budding as oncotarget.

Authors:  Inti Zlobec; Alessandro Lugli
Journal:  Oncotarget       Date:  2010-11

9.  Vascular Invasion and Stromal S100A4 Expression at the Invasive Front of Colorectal Cancer are Novel Determinants and Tumor Prognostic Markers.

Authors:  Tamotsu Sugai; Noriyuki Yamada; Makoto Eizuka; Ryo Sugimoto; Noriyuki Uesugi; Mitsumasa Osakabe; Kazuyuki Ishida; Kouki Otsuka; Akira Sasaki; Takayuki Matsumoto
Journal:  J Cancer       Date:  2017-06-02       Impact factor: 4.207

10.  Prognostic significance of circulating laminin gamma2 for early-stage non-small-cell lung cancer.

Authors:  Yu Teng; Zitong Wang; Li Ma; Lina Zhang; Yinan Guo; Meng Gu; Ziyu Wang; Yue Wang; Wentao Yue
Journal:  Onco Targets Ther       Date:  2016-07-07       Impact factor: 4.147

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.